{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:29:26Z","timestamp":1793950166197,"version":"4.8.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bmc.2021.116453","type":"journal-article","created":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T06:32:29Z","timestamp":1633501949000},"page":"116453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Synthesis of novel indole-thiazolidinone hybrid structures as promising scaffold with anticancer potential"],"prefix":"10.1016","volume":"50","author":[{"given":"Anna","family":"Kryshchyshyn-Dylevych","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Radko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliya","family":"Finiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myroslav","family":"Garazd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliya","family":"Kashchak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Posyniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Niemczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rostyslav","family":"Stoika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Lesyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2021.116453_b0005","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejmech.2013.11.017","article-title":"4-thiazolidinones: the advances continue\u2026","volume":"72","author":"Tripathi","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2021.116453_b0010","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ejmech.2017.09.031","article-title":"5-Ene-4-thiazolidinones \u2013 an efficient tool in medicinal chemistry","volume":"140","author":"Kaminskyy","year":"2017","journal-title":"Eur J Med Chem"},{"issue":"12","key":"10.1016\/j.bmc.2021.116453_b0015","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1080\/17460441.2017.1388370","article-title":"Recent developments with rhodanine as a scaffold for drug discovery","volume":"12","author":"Kaminskyy","year":"2017","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.bmc.2021.116453_b0020","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.4155\/fmc.10.237","article-title":"Observations on screening-based research and some concerning trends in the literature","volume":"2","author":"Baell","year":"2010","journal-title":"Future Med Chem"},{"issue":"2","key":"10.1016\/j.bmc.2021.116453_b0025","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1021\/jm201243p","article-title":"Privileged scaffolds or promiscuous binders: a comparative study on rhodanines and related heterocycles in medicinal chemistry","volume":"55","author":"Mendgen","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116453_b0030","doi-asserted-by":"crossref","first-page":"8400","DOI":"10.1039\/c1ob06065a","article-title":"Predicting Michael-acceptor reactivity and toxicity through quantum chemical transition-state calculations","volume":"9","author":"Mulliner","year":"2011","journal-title":"Org Biomol Chem"},{"issue":"12","key":"10.1016\/j.bmc.2021.116453_b0035","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1021\/tx700319t","article-title":"Toxicological evaluation of thiol-reactive compounds identified using a La Assay to detect reactive molecules by nuclear magnetic resonance","volume":"20","author":"Huth","year":"2007","journal-title":"Chem Res Toxicol"},{"issue":"21","key":"10.1016\/j.bmc.2021.116453_b0040","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/jm058225d","article-title":"Designed multiple ligands. An emerging drug discovery paradigm","volume":"48","author":"Morphy","year":"2005","journal-title":"J Med Chem"},{"issue":"8","key":"10.1016\/j.bmc.2021.116453_b0045","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1517\/17460441.2013.798296","article-title":"Advances in the development of hybrid anticancer drugs","volume":"8","author":"Fortin","year":"2013","journal-title":"Expert Opin Drug Discov"},{"issue":"2","key":"10.1016\/j.bmc.2021.116453_b0050","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/scipharm86020026","article-title":"Thiopyrano[2,3-d]thiazoles as new efficient scaffolds in medicinal chemistry","volume":"86","author":"Kryshchyshyn","year":"2018","journal-title":"Sci Pharm"},{"key":"10.1016\/j.bmc.2021.116453_b0055","doi-asserted-by":"crossref","unstructured":"Wang L, Kong F, Kokoski CL, Andrews DW, Xing C. Bioorg Med Chem Lett 2008; 18(1): 236-240. https:\/\/doi.org\/ 10.1016\/j.bmcl.2007.10.088.","DOI":"10.1016\/j.bmcl.2007.10.088"},{"issue":"5","key":"10.1016\/j.bmc.2021.116453_b0060","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.bmc.2006.12.020","article-title":"Development of selective inhibitors for anti-apoptotic Bcl-2 proteins from BHI-1","volume":"15","author":"Xing","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2021.116453_b0065","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.ejmech.2014.10.025","article-title":"Thiazolidine-2,4-diones as multitargeted scaffold in medicinal chemistry: potential anticancer agents","volume":"87","author":"Asati","year":"2014","journal-title":"Eur J Med Chem"},{"issue":"6","key":"10.1016\/j.bmc.2021.116453_b0070","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1158\/1541-7786.MCR-06-0278","article-title":"Effects of thiazolidinediones on differentiation, proliferation, and apoptosis","volume":"5","author":"Chou","year":"2007","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.bmc.2021.116453_b0075","doi-asserted-by":"crossref","unstructured":"Teraishi F, Wu S, Sasaki J, Zhang L, Zhu H-B, JDavis JJ, Fang B. P-Glycoprotein-independent apoptosis induction by a novel synthetic compound, MMPT 5-(4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone. J Pharmacol Exper Ther 2005; 314(1): 355-362. https:\/\/doi.org\/10.1124\/jpet.105.085654.","DOI":"10.1124\/jpet.105.085654"},{"key":"10.1016\/j.bmc.2021.116453_b0080","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejmech.2017.09.071","article-title":"Anticancer properties of 4-thiazolidinone derivatives depend on peroxisome proliferator-activated receptor gamma (PPAR\u03b3)","volume":"141","author":"Szychowski","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2021.116453_b0085","doi-asserted-by":"crossref","unstructured":"Kryshchyshyn A, Kaminskyy D, Roman O, Kralovics R, Karpenko O, Lesyk R. Synthesis and anti-leukemic activity of pyrrolidinedione-thiazolidinone hybrids. Ukr Biochem J 2020; 92(2): 108-119. https:\/\/doi.org\/10.15407\/ubj92.02.108.","DOI":"10.15407\/ubj92.02.108"},{"key":"10.1016\/j.bmc.2021.116453_b0090","doi-asserted-by":"crossref","unstructured":"Chauhan K, Sharma M, Saxena J, Singh SV, Trivedi P, Srivastava K, Puri SK, Saxena JK, Chaturvedi V, Chauhan PMS. Synthesis and biological evaluation of a new class of 4-aminoquinoline-rhodanine hybrid as potent anti-infective agents. Eur J Med Chem 2013; 62: 693-704. https:\/\/doi.org\/ 10.1016\/j.ejmech.2013.01.017.","DOI":"10.1016\/j.ejmech.2013.01.017"},{"key":"10.1016\/j.bmc.2021.116453_b0095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejmech.2016.02.030","article-title":"Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole\/pyrazoline\u2013thiazolidine\u2013based hybrids","volume":"113","author":"Havrylyuk","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2021.116453_b0100","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ejmech.2019.04.052","article-title":"Thiazolidinone\/thiazole based hybrids \u2013 New class of antitrypanosomal agents","volume":"174","author":"Kryshchyshyn","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2021.116453_b0105","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejmech.2014.10.065","article-title":"A review on recent developments of indole-containing antiviral agents","volume":"89","author":"Zhang","year":"2015","journal-title":"Eur J Med Chem"},{"issue":"9","key":"10.1016\/j.bmc.2021.116453_b0110","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1021\/acsmedchemlett.5b00208","article-title":"Structural optimization of indole derivatives acting at colchicine binding site as potential anticancer agents","volume":"6","author":"Hwang","year":"2015","journal-title":"ACS Med Chem Lett"},{"issue":"1","key":"10.1016\/j.bmc.2021.116453_b0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/1871524915666150608103224","article-title":"Central nervous system activities of indole derivatives: an overview","volume":"16","author":"Saini","year":"2016","journal-title":"Cent Nerv Syst Agents Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2021.116453_b0120","first-page":"9","article-title":"Recent progress in biological activities of indole and indole alkaloids","volume":"18","author":"Singh","year":"2018","journal-title":"Mini Rev Med Chem"},{"issue":"7","key":"10.1016\/j.bmc.2021.116453_b0125","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.2006.06.3602","article-title":"Sunitinib: from rational design to clinical efficacy","volume":"25","author":"Chow","year":"2007","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.bmc.2021.116453_b0130","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1021\/jm101007q","article-title":"Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells","volume":"54","author":"Granchi","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116453_b0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejmech.2016.04.039","article-title":"Synthesis and preliminary evaluation of 3-thiocyanato-1H-indoles as potential anticancer agents","volume":"118","author":"Fortes","year":"2016","journal-title":"Eur J Med Chem"},{"issue":"8","key":"10.1016\/j.bmc.2021.116453_b0140","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1016\/j.ejmech.2011.05.017","article-title":"Design, synthesis and biological evaluation of novel 4-thiazolidinones containing indolin-2-one moiety as potential antitumor agent","volume":"46","author":"Wang","year":"2011","journal-title":"Eur J Med Chem"},{"issue":"18","key":"10.1016\/j.bmc.2021.116453_b0145","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1080\/00397911.2020.1786124","article-title":"Synthesis and anticancer activity evaluation of 3-(4-oxo-2-thioxothiazolidin-5-yl)-1H-indole-carboxylic acids derivatives","volume":"50","author":"Kryshchyshyn","year":"2020","journal-title":"Synth Comm"},{"key":"10.1016\/j.bmc.2021.116453_b0150","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/d41591-019-00016-7","article-title":"When there\u2019s more than one way to target a cancer","volume":"25","author":"May","year":"2019","journal-title":"Nat Med"},{"issue":"18","key":"10.1016\/j.bmc.2021.116453_b0155","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.4155\/fmc-2019-0185","article-title":"Multi-target ABC transporter modulators: what next and where to go?","volume":"11","author":"Stefan","year":"2019","journal-title":"Future Med Chem"},{"issue":"8","key":"10.1016\/j.bmc.2021.116453_b0160","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2174\/13816128113199990066","article-title":"Network-based strategies can help mono- and poly-pharmacology drug discovery: a systems biology view","volume":"20","author":"Engin","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bmc.2021.116453_b0165","first-page":"2993","article-title":"Selective cytotoxic activities of two novel synthetic drugs on human breast carcinoma MCF-7 cells","volume":"29","author":"Badisa","year":"2009","journal-title":"Anticancer Res"},{"issue":"11","key":"10.1016\/j.bmc.2021.116453_b0170","first-page":"1","article-title":"Comb-like PEG-containing polymeric composition as low toxic drug nanocarrier","volume":"9","author":"Kobylinska","year":"2018","journal-title":"Cancer Nano"},{"key":"10.1016\/j.bmc.2021.116453_b0175","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s11671-019-2945-7","article-title":"Enhanced proapoptotic effects of water dispersed complexes of 4-thiazolidinone-based chemotherapeutics with a PEG-containing polymeric nanocarrier","volume":"14","author":"Kobylinska","year":"2019","journal-title":"Nanoscale Res Lett"},{"key":"10.1016\/j.bmc.2021.116453_b0180","doi-asserted-by":"crossref","unstructured":"Kobylinska L, Klyuchivska O, Lesyk R, Stoika R. Targeting of the pro-oxidant-antioxidant balance in vitro and in vivo by 4-thiazolidinone-based chemotherapeutics with anticancer potential. Ukr Biochem J 2019; 91(2): 7-17. https:\/\/doi.org\/10.15407\/ubj91.02.007.","DOI":"10.15407\/ubj91.02.007"},{"issue":"7","key":"10.1016\/j.bmc.2021.116453_b0185","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1166\/jbn.2014.1864","article-title":"Enhanced anticancer activity and circumvention of resistance mechanisms by novel polymeric\/phospholipidic nanocarriers of doxorubicin","volume":"10","author":"Senkiv","year":"2014","journal-title":"J Biomed Nanotechnol"},{"issue":"5","key":"10.1016\/j.bmc.2021.116453_b0190","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1166\/jbn.2014.1763","article-title":"Nanoformulation improves activity of the (pre)clinical anticancer ruthenium complex KP1019","volume":"10","author":"Heffeter","year":"2014","journal-title":"J Biomed Nanotechnol"},{"key":"10.1016\/j.bmc.2021.116453_b0195","unstructured":"Kobylinska LI, Havrylyuk DYa, Ryabtseva AO, Mitina NE, Zaichenko OS, Lesyk RB, Zimenkovsky BS, Stoika RS. Biochemical indicators of hepatotoxicity in blood serum of rats under the effect of novel 4-thiazolidinone derivatives and doxorubicin and their complexes with polyethyleneglycol-containing nanoscale polymeric carrier. Ukr Biochem J 2015; 87(2): 122\u2013132."},{"key":"10.1016\/j.bmc.2021.116453_b0200","doi-asserted-by":"crossref","unstructured":"Kobylinska LI, Havrylyuk DYa, Mitina NE, Zaichenko AS, Lesyk RB, Zimenkovsky BS, Stoika RS. Biochemical indicators of nephrotoxicity in blood serum of rats treated with novel 4-thiazolidinone derivatives or their complexes with polyethyleneglycol-containing nanoscale polymeric carrier. Ukr Biochem J 2016; 88(1): 51\u201360. https:\/\/doi.org\/10.15407 \/ubj88.01.051.","DOI":"10.15407\/ubj88.01.051"},{"key":"10.1016\/j.bmc.2021.116453_b0205","doi-asserted-by":"crossref","unstructured":"Zhang MY, Wang JP. A multi-target protein of hTERTR-FAM96A presents significant anticancer potent in the treatment of hepatocellular carcinoma. Tumour Biol 2017; 39(4): 1010428317698341. https:\/\/doi.org\/10.1177\/1010428317698341.","DOI":"10.1177\/1010428317698341"},{"key":"10.1016\/j.bmc.2021.116453_b0210","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-3-030-20301-6_4","article-title":"Breast cancer: current perspectives on the disease status","volume":"1152","author":"Fahad","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.bmc.2021.116453_b0215","doi-asserted-by":"crossref","unstructured":"Nelson VK, Sahoo NK, Sahu M, Sudhan HH, Pullaiah CP, Muralikrishna KS. In vitro anticancer activity of Eclipta alba whole plant extract on colon cancer cell HCT-116. BMC Complement Med Ther 2020; 20(1): 355. https:\/\/doi.org\/doi:10.1186\/s12906-020-03118-9.","DOI":"10.1186\/s12906-020-03118-9"},{"issue":"4","key":"10.1016\/j.bmc.2021.116453_b0220","article-title":"Caspase functions in cell death and disease","volume":"5","author":"McIlwain","year":"2013","journal-title":"CSH Perspect Biol"},{"issue":"2","key":"10.1016\/j.bmc.2021.116453_b0225","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/15384101.2017.1407891","article-title":"VEGFC\/VEGFR3 Signaling Regulates Mouse Spermatogonial Cell Proliferation via the Activation of AKT\/MAPK and Cyclin D1 Pathway and Mediates the Apoptosis by affecting Caspase 3\/9 and Bcl-2","volume":"17","author":"Zhao","year":"2018","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.bmc.2021.116453_b0230","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/07853890600551037","article-title":"Targeting the ERK signaling pathway in cancer therapy","volume":"38","author":"Kohno","year":"2006","journal-title":"Ann Med"},{"issue":"3","key":"10.1016\/j.bmc.2021.116453_b0235","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1535-6108(02)00126-5","article-title":"BAX and BAK mediate p53-independent suppression of tumorigenesis","volume":"2","author":"Degenhardt","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bmc.2021.116453_b0240","first-page":"1564","article-title":"P53, Bcl2 and Bax expression and apoptosis in perifosine and vitamin D-treated endometrial cancer cell line (HEC1A)","volume":"2","author":"Karag\u00fcl","year":"2018","journal-title":"Proc"},{"issue":"2","key":"10.1016\/j.bmc.2021.116453_b0245","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nrc.2016.138","article-title":"Cell cycle proteins as promising targets in cancer therapy","volume":"17","author":"Otto","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"10.1016\/j.bmc.2021.116453_b0250","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3390\/molecules21121758","article-title":"Cryptolepine, a plant alkaloid, inhibits the growth of non-melanoma skin cancer cells through inhibition of topoisomerase and induction of DNA damage","volume":"21","author":"Pal","year":"2016","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.bmc.2021.116453_b0255","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.3390\/ijms18081784","article-title":"A critical review on the effect of docosahexaenoic acid (DHA) on cancer cell cycle progression","volume":"18","author":"Newell","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.bmc.2021.116453_b0260","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/jmcb\/mju045","article-title":"CHK2 kinase in the DNA damage response and beyond","volume":"6","author":"Zannini","year":"2014","journal-title":"J Mol Cell Biol"},{"issue":"11","key":"10.1016\/j.bmc.2021.116453_b0265","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.4155\/fmc-2016-0047","article-title":"Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents, an update (2013\u20132015)","volume":"8","author":"Patil","year":"2016","journal-title":"Future Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2021.116453_b0270","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jat.3658","article-title":"In vitro assays and techniques utilized in anticancer drug discovery","volume":"39","author":"Ediriweera","year":"2019","journal-title":"Appl Toxicol"},{"issue":"9","key":"10.1016\/j.bmc.2021.116453_b0275","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2174\/1568009614666141128105146","article-title":"Interactions of cisplatin with non-DNA targets and their influence on anticancer activity and drug toxicity: the complex world of the platinum complex","volume":"14","author":"Mezencev","year":"2015","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.bmc.2021.116453_b0280","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3892\/ol.2015.3879","article-title":"The effects of buthionine sulfoximine on the proliferation and apoptosis of biliary tract cancer cells induced by cisplatin and gemcitabine","volume":"11","author":"Li","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.bmc.2021.116453_b0285","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.bmc.2021.116453_b0290","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.3390\/molecules24101949","article-title":"Silver(I) complexes of the pharmaceutical agents metronidazole and 4-hydroxymethylpyridine: comparison of cytotoxic profile for potential clinical application","volume":"24","author":"Radko","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2021.116453_b0295","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0378-4274(85)90046-3","article-title":"Toxicity determined in vitro by morphological alterations and neutral red absorption","volume":"24","author":"Borenfreund","year":"1985","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.bmc.2021.116453_b0300","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bmc.2021.116453_b0305","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0022-1759(83)90438-6","article-title":"An enzyme-release assay for natural cytotoxicity","volume":"64","author":"Korzeniewski","year":"1983","journal-title":"J Immunol Methods"},{"issue":"8","key":"10.1016\/j.bmc.2021.116453_b0310","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3390\/molecules21081013","article-title":"Cytotoxicity, post-treatment recovery, and selectivity analysis of naturally occurring podophyllotoxins from Bursera fagaroides var. fagaroides on breast cancer cell lines","volume":"21","author":"Pe\u00f1a-Mor\u00e1n","year":"2016","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.bmc.2021.116453_b0315","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4103\/1947-2714.100998","article-title":"Western blot: technique, theory, and trouble shooting","volume":"4","author":"Mahmood","year":"2012","journal-title":"N Am J Med Sci"},{"issue":"1","key":"10.1016\/j.bmc.2021.116453_b0320","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ymeth.2009.02.016","article-title":"The comet assay: a sensitive method for detecting DNA damage in individual cells","volume":"48","author":"Liao","year":"2009","journal-title":"Methods"},{"issue":"1\u20132","key":"10.1016\/j.bmc.2021.116453_b0325","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1383-5718(02)00251-6","article-title":"A cross platform public domain PC image analysis program for the comet assay","volume":"534","author":"Ko\u0144ca","year":"2003","journal-title":"Mutat Res"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621004612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621004612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:15:19Z","timestamp":1760836519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089621004612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":65,"alternative-id":["S0968089621004612"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116453","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of novel indole-thiazolidinone hybrid structures as promising scaffold with anticancer potential","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116453","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116453"}}